Procalcitonin to Predict Infection After Gastrectomy for Gastric Cancer

NCT03780439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 552

Last updated 2019-09-24

No results posted yet for this study

Summary

To investigate the diagnostic accuracy of procalcitonin as an early predictor of infection after radical gastrectomy for gastric cancer.

Conditions

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    collaborator OTHER
  • Yongchang Zhang

    lead OTHER

Principal Investigators

  • Hua Xiao · Hunan Cancer Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-07-28
Completion
2019-07-28

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780439 on ClinicalTrials.gov